Skip to content
TrialScanner

NCT02637557

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Phase 2CompletedIRWDLead

Registry record

Lead sponsor
Ironwood Pharmaceuticals, Inc.
Conditions
Gastroesophageal Reflux Disease
Primary completion
Apr 26, 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02637557 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02637557: A Trial of IW-3718 for 8... | TrialScanner